Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | WM-8014 |
| Synonyms | |
| Therapy Description |
WM-8014 selectively inhibits KAT6A and KAT6B, which potentially results in induction of cellular senescence and inhibition of tumor cell proliferation (PMID: 30069049). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| WM-8014 | MOZ-IN-3 | WM-8014 selectively inhibits KAT6A and KAT6B, which potentially results in induction of cellular senescence and inhibition of tumor cell proliferation (PMID: 30069049). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| HRAS G12V | Advanced Solid Tumor | sensitive | WM-8014 | Preclinical | Actionable | In a preclinical study, WM-8014 inhibited proliferation of a transformed mouse cell line expressing HRAS G12V in culture, and inhibited proliferation and induced senescence in a transgenic zebrafish model (PMID: 30069049). | 30069049 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|